Metraipolis › archive › dc_d53a1087f694

Development of PSMA-Targeted Liposomal Zinc for Prostate Cancer Therapy — Europe PMC PMID:42347272

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42347272
DOI
10.3390/nano16120705
License (as archived)
solo-consultazione
Archived
2026-10-31T17:01:12.700Z
SHA-256 of the archived text
e650133931aa048cdc821b0c80b8fc9450650fe12bf8fe0990cb4264ae7c5e16
Stable URL of this page
https://metraipolis.com/documento/dc_d53a1087f694

How to cite

Development of PSMA-Targeted Liposomal Zinc for Prostate Cancer Therapy — Europe PMC PMID:42347272 — Europe PMC (en), https://europepmc.org/article/MED/42347272 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d53a1087f694 (Metraipolis archive dc_d53a1087f694, sha256 e650133931aa048cdc821b0c80b8fc9450650fe12bf8fe0990cb4264ae7c5e16)
BibTeX
@misc{dcd53a1087f694,
  title = {Development of PSMA-Targeted Liposomal Zinc for Prostate Cancer Therapy — Europe PMC PMID:42347272},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42347272},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d53a1087f694; sha256 e650133931aa048cdc821b0c80b8fc9450650fe12bf8fe0990cb4264ae7c5e16},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42347272. Agents can read the archived copy with the MCP tool read_document.